Rodin Therapeutics, Inc.
Acquired
Matched to this startup by its exact name; the buyer's report is the source.
| Acquired | Buyer | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|---|
| Rodin Therapeutics, Inc | Alkermes plc. | Nov 2019 | — | — | — | Annual report |
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2017 | $11 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Rodin Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2017).
SEC Form D · Sep 2017
The industry group it chose in its notices: Other Health Care.
SEC Form D · Sep 2017
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Rodin Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Adam Rosenberg | Executive officer | Sep 2017 |
| Adam Rosenberg | Director | Sep 2017 |
| Bruce Booth | Director | Sep 2017 |
| Kees Been | Director | Sep 2017 |
| Samantha Singer | Director | Sep 2017 |
Acquired (Jan 1, 2019). Acquired by Alkermes plc..